Diagnosis and Quantitation of Fibrosis

Abdi, 1979, Sampling variability on percutaneous liver biopsy, Arch Intern Med, 139, 667, 10.1001/archinte.139.6.667 Regev, 2002, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, Am J Gastroenterol, 97, 2614, 10.1111/j.1572-0241.2002.06038.x Imbert-Bismut, 2001, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, Lancet, 357, 1069, 10.1016/S0140-6736(00)04258-6 Poynard, 2004, Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C, Comp Hepatol, 3, 8, 10.1186/1476-5926-3-8 Harbin, 1980, Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis, Radiology, 135, 273, 10.1148/radiology.135.2.7367613 Ziol, 2005, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C, Hepatology, 41, 48, 10.1002/hep.20506 Verveer, 2006, Noninvasive measurement of liver fibrosis: application of the FibroScan in hepatology, Scand J Gastroenterol Suppl, 85, 10.1080/00365520600664359 Huwart, 2006, Liver fibrosis: non-invasive assessment with MR elastography, NMR Biomed, 19, 173, 10.1002/nbm.1030 Menghini, 1958, One-second needle biopsy of the liver, Gastroenterology, 35, 190, 10.1016/S0016-5085(19)35563-5 Froehlich, 1993, Practice and complications of liver biopsy, Dig Dis Sci, 38, 1480, 10.1007/BF01308607 Lindor, 1996, The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy, Hepatology, 23, 1079, 10.1002/hep.510230522 Perrault, 1978, Liver biopsy: complications in 1000 inpatients and outpatients, Gastroenterology, 74, 103, 10.1016/0016-5085(78)90364-5 Thampanitchawong, 1999, Liver biopsy: complications and risk factors, World J Gastroenterol, 5, 301, 10.3748/wjg.v5.i4.301 Terjung, 2003, Bleeding complications after percutaneous liver biopsy, Digestion, 67, 138, 10.1159/000071293 Poniachik, 1996, The role of laparoscopy in the diagnosis of cirrhosis, Gastrointest Endosc, 43, 568, 10.1016/S0016-5107(96)70192-X Pagliaro, 1983, Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis, Dig Dis Sci, 28, 39, 10.1007/BF01393359 Maharaj, 1986, Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver, Lancet, 1, 523, 10.1016/S0140-6736(86)90883-4 Schlichting, 1983, Liver biopsy in chronic aggressive hepatitis, Scand J Gastroenterol, 18, 27, 10.3109/00365528309181554 Holund, 1980, Reproducibility of liver biopsy diagnosis in relation to the size of the specimen, Scand J Gastroenterol, 15, 329, 10.3109/00365528009181479 Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, 38, 1449, 10.1016/j.hep.2003.09.022 Poynard, 2004, Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C, Clin Chem, 50, 1344, 10.1373/clinchem.2004.032227 Colombo, 1988, Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis, Gastroenterology, 95, 487, 10.1016/0016-5085(88)90509-4 Vargas-Tank, 1985, Tru-cut and Menghini needles: different yield in the histological diagnosis of liver disease, Liver, 5, 178, 10.1111/j.1600-0676.1985.tb00234.x Oberti, 1997, Noninvasive diagnosis of hepatic fibrosis or cirrhosis, Gastroenterology, 113, 1609, 10.1053/gast.1997.v113.pm9352863 Bedossa, 1988, Observer variation in assessment of liver biopsies of alcoholic patients, Alcohol Clin Exp Res, 12, 173, 10.1111/j.1530-0277.1988.tb00155.x Westin, 1999, Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection, Liver, 19, 183, 10.1111/j.1478-3231.1999.tb00033.x Bedossa, 1994, Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C, Hepatology, 20, 15, 10.1002/hep.1840200104 Pilette, 1998, Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores, J Hepatol, 28, 439, 10.1016/S0168-8278(98)80318-8 Goldin, 1996, Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis, J Hepatol, 25, 649, 10.1016/S0168-8278(96)80234-0 O'Brien, 2000, An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C, Am J Clin Pathol, 114, 712, 10.1309/D7AU-EYW7-4B6C-K08Y Zaitoun, 2001, Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C, J Clin Pathol, 54, 461, 10.1136/jcp.54.6.461 Goodman, 2007, Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis, Hepatology, 45, 886, 10.1002/hep.21595 Parkes, 2006, Performance of serum marker panels for liver fibrosis in chronic hepatitis C, J Hepatol, 44, 462, 10.1016/j.jhep.2005.10.019 Friedman, 2003, Liver fibrosis—from bench to bedside, J Hepatol, 38, S38, 10.1016/S0168-8278(02)00429-4 Afdhal, 2004, Evaluation of liver fibrosis: a concise review, Am J Gastroenterol, 99, 1160, 10.1111/j.1572-0241.2004.30110.x Hayasaka, 1990, Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease, J Hepatol, 10, 17, 10.1016/0168-8278(90)90067-2 Castera, 2000, Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis, J Hepatol, 32, 412, 10.1016/S0168-8278(00)80391-8 Kasahara, 1997, Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C, J Hepatol, 26, 574, 10.1016/S0168-8278(97)80423-0 McHutchison, 2000, Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology, J Gastroenterol Hepatol, 15, 945, 10.1046/j.1440-1746.2000.02233.x Murawaki, 1994, Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology, Hepatology, 20, 780, 10.1002/hep.1840200403 Trinchet, 1995, Clinical use of serum markers of fibrosis in chronic hepatitis, J Hepatol, 22, 89 Schuppan, 1990, Undulin, an extracellular matrix glycoprotein associated with collagen fibrils, J Biol Chem, 265, 8823, 10.1016/S0021-9258(19)38962-8 Forns, 2002, Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model, Hepatology, 36, 986, 10.1053/jhep.2002.36128 Yamauchi, 1994, Serum tenascin levels in chronic liver disease, Liver, 14, 148, 10.1111/j.1600-0676.1994.tb00064.x Thabut, 2003, Noninvasive prediction of fibrosis in patients with chronic hepatitis C, Hepatology, 37, 1220, 10.1053/jhep.2003.50109 Wai, 2003, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, 38, 518, 10.1053/jhep.2003.50346 Assy, 2000, Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults, Am J Gastroenterol, 95, 1545, 10.1111/j.1572-0241.2000.02027.x Anderson, 2000, An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C, Hepatol Res, 18, 63, 10.1016/S1386-6346(99)00085-6 Park, 2000, Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?, J Gastroenterol Hepatol, 15, 386, 10.1046/j.1440-1746.2000.02172.x Sheth, 1998, AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection, Am J Gastroenterol, 93, 44, 10.1111/j.1572-0241.1998.044_c.x Imperiale, 2000, Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C, Am J Gastroenterol, 95, 2328, 10.1111/j.1572-0241.2000.02322.x Schalm, 1997, The diagnosis of cirrhosis: clinical relevance and methodology, J Hepatol, 27, 1118, 10.1016/S0168-8278(97)80159-6 Kawasaki, 1999, Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, Am J Gastroenterol, 94, 1918, 10.1111/j.1572-0241.1999.01231.x Aster, 1966, Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia, J Clin Invest, 45, 645, 10.1172/JCI105380 Kamimoto, 1985, Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells, Hepatology, 5, 367, 10.1002/hep.1840050305 Castera, 2005, Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C, Gastroenterology, 128, 343, 10.1053/j.gastro.2004.11.018 Kelleher, 2005, Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index, J Hepatol, 43, 78, 10.1016/j.jhep.2005.02.025 Islam, 2005, Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers, Scand J Gastroenterol, 40, 867, 10.1080/00365520510015674 Lackner, 2005, Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C, Hepatology, 41, 1376, 10.1002/hep.20717 Schiavon, 2007, Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection, Hepatology, 46, 307, 10.1002/hep.21681 Lieber, 2006, Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis, Am J Gastroenterol, 101, 1500, 10.1111/j.1572-0241.2006.00610.x Shaheen, 2007, Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review, Hepatology, 46, 912, 10.1002/hep.21835 Poynard, 1991, A simple biological index for detection of alcoholic liver disease in drinkers, Gastroenterology, 100, 1397, 10.1016/0016-5085(91)70030-2 Teare, 1993, Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis, Lancet, 342, 895, 10.1016/0140-6736(93)91946-J Myers, 2003, Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients, Aids, 17, 721, 10.1097/00002030-200303280-00010 Myers, 2003, Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index, Dig Dis Sci, 48, 146, 10.1023/A:1021702902681 Rossi, 2003, Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients, Clin Chem, 49, 450, 10.1373/49.3.450 Poynard, 2007, Meta-analyses of Fibrotest diagnostic value in chronic liver disease, BMC Gastroenterol, 7, 40, 10.1186/1471-230X-7-40 Sebastiani, 2006, Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C, J Hepatol, 44, 686, 10.1016/j.jhep.2006.01.007 Halfon, 2002, A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease, Comp Hepatol, 1, 3, 10.1186/1476-5926-1-3 Poynard, 2002, Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial, J Viral Hepat, 9, 128, 10.1046/j.1365-2893.2002.00341.x Poynard, 2003, Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin, Hepatology, 38, 481, 10.1053/jhep.2003.50319 Halfon, 2006, Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the Fibropaca study, Am J Gastroenterol, 101, 547, 10.1111/j.1572-0241.2006.00411.x Koda, 2007, FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C, Hepatology, 45, 297, 10.1002/hep.21520 Adams, 2005, Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection, Clin Chem, 51, 1867, 10.1373/clinchem.2005.048389 Vallet-Pichard, 2007, FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection, Hepatology, 46, 32, 10.1002/hep.21669 Sterling, 2006, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, 43, 1317, 10.1002/hep.21178 Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496 Poynard, 2007, Direct comparison of two non invasive biomarkers for the diagnosis of advanced fibrosis in patients with non alcoholic fatty liver disease (NAFLD): NAFLD score and FibroTest, Hepatology, 46, 1 Pohl, 2001, Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection, Am J Gastroenterol, 96, 3142, 10.1111/j.1572-0241.2001.05268.x Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 McGary, 1989, Endocytosis of hyaluronic acid by rat liver endothelial cells, Biochem J, 257, 875, 10.1042/bj2570875 Guechot, 1996, Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis, Clin Chem, 42, 558, 10.1093/clinchem/42.4.558 Murawaki, 2001, Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C, J Gastroenterol, 36, 399, 10.1007/s005350170084 Pares, 1996, Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis, Hepatology, 24, 1399, 10.1002/hep.510240615 Idobe, 1998, Post-prandial serum hyaluronan concentration in patients with chronic liver disease, Intern Med, 37, 568, 10.2169/internalmedicine.37.568 Montalto, 1996, Procollagen III and laminin in chronic viral hepatopathies, Presse Med, 25, 59 Trinchet, 1991, Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis, J Hepatol, 12, 139, 10.1016/0168-8278(91)90929-6 Nouchi, 1987, Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease, Alcohol Clin Exp Res, 11, 287, 10.1111/j.1530-0277.1987.tb01309.x Niemela, 1990, Markers of fibrogenesis and basement membrane formation in alcoholic liver disease, Gastroenterology, 98, 1612, 10.1016/0016-5085(90)91098-Q Giannini, 2001, Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C, Eur J Gastroenterol Hepatol, 13, 137, 10.1097/00042737-200102000-00008 Gabrielli, 1997, Serum laminin and type III procollagen in chronic hepatitis C, Clin Chim Acta, 265, 21, 10.1016/S0009-8981(97)00103-4 Maurice, 2005, Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen, Br J Dermatol, 152, 451, 10.1111/j.1365-2133.2005.06459.x Khan, 2006, Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis, Postgrad Med J, 82, 353, 10.1136/pgmj.2005.041533 Chalmers, 2005, Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis, Br J Dermatol, 152, 444, 10.1111/j.1365-2133.2005.06422.x Hahn, 1980, Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin, Gut, 21, 63, 10.1136/gut.21.1.63 George, 1999, Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis, J Hepatol, 31, 47, 10.1016/S0168-8278(99)80162-7 Ueno, 1992, Significance of serum type-IV collagen levels in various liver diseases, Scand J Gastroenterol, 27, 513, 10.3109/00365529209000114 Matsumoto, 1999, Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition, Liver, 19, 32, 10.1111/j.1478-3231.1999.tb00006.x Walsh, 2000, Basement membrane peptides as markers of liver disease in chronic hepatitis C, J Hepatol, 32, 325, 10.1016/S0168-8278(00)80079-3 Misaki, 1990, Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease, Clin Chem, 36, 522, 10.1093/clinchem/36.3.522 Benyon, 2001, Extracellular matrix degradation and the role of hepatic stellate cells, Semin Liver Dis, 21, 373, 10.1055/s-2001-17552 Arthur, 2000, Fibrogenesis II, Am J Physiol Gastrointest Liver Physiol, 279, G245, 10.1152/ajpgi.2000.279.2.G245 Fabris, 1999, Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN, J Gastroenterol, 34, 345, 10.1007/s005350050272 Walsh, 1999, Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis, Dig Dis Sci, 44, 624, 10.1023/A:1026630129025 Boeker, 2002, Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C, Clin Chim Acta, 316, 71, 10.1016/S0009-8981(01)00730-6 Murawaki, 1999, Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease, J Hepatol, 31, 474, 10.1016/S0168-8278(99)80040-3 Hayasaka, 1996, Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma, Hepatology, 24, 1058, 10.1002/hep.510240513 Benyon, 1996, Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver, Gastroenterology, 110, 821, 10.1053/gast.1996.v110.pm8608892 Iredale, 1995, Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes, Clin Sci (Lond), 89, 75, 10.1042/cs0890075 Larrousse, 2007, Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients, J Acquir Immune Defic Syndr, 46, 304, 10.1097/QAI.0b013e3181520502 Johansen, 2000, Serum YKL-40 is increased in patients with hepatic fibrosis, J Hepatol, 32, 911, 10.1016/S0168-8278(00)80095-1 Nojgaard, 2003, Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease, J Hepatol, 39, 179, 10.1016/S0168-8278(03)00184-3 Zheng, 2005, Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value, Acta Trop, 96, 148, 10.1016/j.actatropica.2005.07.009 Nelson, 1997, Transforming growth factor-β 1 in chronic hepatitis C, J Viral Hepat, 4, 29, 10.1046/j.1365-2893.1997.00124.x Kanzler, 2001, Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β, J Viral Hepat, 8, 430, 10.1046/j.1365-2893.2001.00314.x McClain, 1989, Increased tumor necrosis factor production by monocytes in alcoholic hepatitis, Hepatology, 9, 349, 10.1002/hep.1840090302 Ikura, 1997, Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease, J Gastroenterol, 32, 496, 10.1007/BF02934089 Shiraishi, 1994, Increased release of platelet-derived growth factor from platelets in chronic liver disease, Eur J Clin Chem Clin Biochem, 32, 5 Patel, 2004, Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients, J Hepatol, 41, 935, 10.1016/j.jhep.2004.08.008 Zaman, 2007, Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients, Am J Med, 120, 280, 10.1016/j.amjmed.2006.06.044 Christensen, 2006, Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients, J Viral Hepat, 13, 652, 10.1111/j.1365-2893.2006.00743.x Rosenberg, 2004, Serum markers detect the presence of liver fibrosis: a cohort study, Gastroenterology, 127, 1704, 10.1053/j.gastro.2004.08.052 Callewaert, 2004, Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics, Nat Med, 10, 429, 10.1038/nm1006 Honda, 1990, Chronic liver disease: value of volumetry of liver and spleen with computed tomography, Radiat Med, 8, 222 Hess, 1989, Diagnosis of liver cirrhosis with US: receiver-operating characteristic analysis of multidimensional caudate lobe indexes, Radiology, 171, 349, 10.1148/radiology.171.2.2649915 Gaiani, 1997, What is the criterion for differentiating chronic hepatitis from compensated cirrhosis?, J Hepatol, 27, 979, 10.1016/S0168-8278(97)80140-7 Aube, 1999, Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis, J Hepatol, 30, 472, 10.1016/S0168-8278(99)80107-X Sandrin, 2002, Shear elasticity probe for soft tissues with 1-D transient elastography, IEEE Trans Ultrason Ferroelectr Freq Control, 49, 436, 10.1109/58.996561 Sandrin, 2003, Transient elastography: a new noninvasive method for assessment of hepatic fibrosis, Ultrasound Med Biol, 29, 1705, 10.1016/j.ultrasmedbio.2003.07.001 Kettaneh, 2007, Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients, J Hepatol, 46, 628, 10.1016/j.jhep.2006.11.010 Yeh, 2002, Elastic modulus measurements of human liver and correlation with pathology, Ultrasound Med Biol, 28, 467, 10.1016/S0301-5629(02)00489-1 Talwalkar, 2007, Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis, Clin Gastroenterol Hepatol, 5, 1214, 10.1016/j.cgh.2007.07.020 Shaheen, 2007, FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy, Am J Gastroenterol, 102, 2589, 10.1111/j.1572-0241.2007.01466.x Huwart, 2007, Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index, Radiology, 245, 458, 10.1148/radiol.2452061673 Yin, 2007, Assessment of hepatic fibrosis with magnetic resonance elastography, Clin Gastroenterol Hepatol, 5, 1207, 10.1016/j.cgh.2007.06.012 Malik, 2007, Stiffness and impedance: the new liver biomarkers, Clin Gastroenterol Hepatol, 5, 1144, 10.1016/j.cgh.2007.07.024 Patel, 2004, Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients, J Hepatol, 41, 935, 10.1016/j.jhep.2004.08.008